Galena Biopharma (GALE +6.8%) initiated at Outperform at Oppenheimer. Price target is $6.
Veracyte (VCYT +7%) started at Outperform at Leerink (PT $17), William Blair, and Cowen (PT $16).
Surgical Care Affiliates (SCAI +2.8%) initiated at Buy at BofA. Price target is $34. Yesterday: Goldman starts SCAI at Neutral.
Heartware (HTWR +2.3%) started at Buy at CRT Capital. Price target is $109.
Mallinckrodt (MNK +2%) initiated at Buy at Jefferies. Price target is $60.
Harvard Bioscience (HBIO +4.4%) upgraded to Buy from Neutral at Sidoti.
Forest Labs (FRX +1.1%) upgraded to Neutral from Underweight at Piper. Price target hiked to $49 from $33.
Cardiovascular Systems (CSII +0.9%) cut to Hold at Benchmark. Price target is $35.